CD44 and neoplasm: Soluble biglycan can interact with different combinations of multiple surface receptors, including toll-like receptors (TLRs) 2 and 4, CD14 and CD44, that in turn influence processes such as autophagy, angiogenesis, cell growth and migration, to finally promote tumor progression or suppression.